109 related articles for article (PubMed ID: 33235326)
1. Author Correction: The nuclear export protein XPO1 - from biology to targeted therapy.
Azmi AS; Uddin MH; Mohammad RM
Nat Rev Clin Oncol; 2021 Mar; 18(3):190. PubMed ID: 33235326
[No Abstract] [Full Text] [Related]
2. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
3. STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes.
Martin AP; Jacquemyn M; Lipecka J; Chhuon C; Aushev VN; Meunier B; Singh MK; Carpi N; Piel M; Codogno P; Hergovich A; Parrini MC; Zalcman G; Guerrera IC; Daelemans D; Camonis JH
EMBO Rep; 2019 Nov; 20(11):e48150. PubMed ID: 31544310
[TBL] [Abstract][Full Text] [Related]
4. Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis.
Taylor J; Sendino M; Gorelick AN; Pastore A; Chang MT; Penson AV; Gavrila EI; Stewart C; Melnik EM; Herrejon Chavez F; Bitner L; Yoshimi A; Lee SC; Inoue D; Liu B; Zhang XJ; Mato AR; Dogan A; Kharas MG; Chen Y; Wang D; Soni RK; Hendrickson RC; Prieto G; Rodriguez JA; Taylor BS; Abdel-Wahab O
Cancer Discov; 2019 Oct; 9(10):1452-1467. PubMed ID: 31285298
[TBL] [Abstract][Full Text] [Related]
5. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.
Camus V; Miloudi H; Taly A; Sola B; Jardin F
J Hematol Oncol; 2017 Feb; 10(1):47. PubMed ID: 28196522
[TBL] [Abstract][Full Text] [Related]
6. Understanding XPO1 target networks using systems biology and mathematical modeling.
Muqbil I; Kauffman M; Shacham S; Mohammad RM; Azmi AS
Curr Pharm Des; 2014; 20(1):56-65. PubMed ID: 23530499
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous mutation of cysteine528 in XPO1 is sufficient for resistance to selective inhibitors of nuclear export.
Neggers JE; Vanstreels E; Baloglu E; Shacham S; Landesman Y; Daelemans D
Oncotarget; 2016 Oct; 7(42):68842-68850. PubMed ID: 27634897
[TBL] [Abstract][Full Text] [Related]
8. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression.
Aboukameel A; Muqbil I; Baloglu E; Senapedis W; Landesman Y; Argueta C; Kauffman M; Chang H; Kashyap T; Shacham S; Neggers JE; Daelemans D; Heath EI; Azmi AS
Oncotarget; 2018 Oct; 9(82):35327-35342. PubMed ID: 30450161
[TBL] [Abstract][Full Text] [Related]
10. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
[TBL] [Abstract][Full Text] [Related]
11.
Miloudi H; Bohers É; Guillonneau F; Taly A; Gibouin VC; Viailly PJ; Jego G; Grumolato L; Jardin F; Sola B
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33007990
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Chen Y; Camacho SC; Silvers TR; Razak AR; Gabrail NY; Gerecitano JF; Kalir E; Pereira E; Evans BR; Ramus SJ; Huang F; Priedigkeit N; Rodriguez E; Donovan M; Khan F; Kalir T; Sebra R; Uzilov A; Chen R; Sinha R; Halpert R; Billaud JN; Shacham S; McCauley D; Landesman Y; Rashal T; Kauffman M; Mirza MR; Mau-Sørensen M; Dottino P; Martignetti JA
Clin Cancer Res; 2017 Mar; 23(6):1552-1563. PubMed ID: 27649553
[No Abstract] [Full Text] [Related]
13. NEDD4 protects vascular endothelial cells against Angiotensin II-induced cell death via enhancement of XPO1-mediated nuclear export.
Xu J; Sheng Z; Li F; Wang S; Yuan Y; Wang M; Yu Z
Exp Cell Res; 2019 Oct; 383(1):111505. PubMed ID: 31326389
[TBL] [Abstract][Full Text] [Related]
14. A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds.
Crochiere ML; Baloglu E; Klebanov B; Donovan S; Del Alamo D; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2016 Jan; 7(2):1863-77. PubMed ID: 26654943
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action.
Wu S; Zhang K; Qin H; Niu M; Zhao W; Ye M; Zou H; Yang Y
Chem Biol Drug Des; 2017 May; 89(5):655-662. PubMed ID: 27863053
[TBL] [Abstract][Full Text] [Related]
16. XPO1-mediated nuclear export of RNF146 protects from angiotensin II-induced endothelial cellular injury.
Sheng Z; Xu Y; Wang S; Yuan Y; Huang T; Lu P
Biochem Biophys Res Commun; 2018 Sep; 503(3):1544-1549. PubMed ID: 30029878
[TBL] [Abstract][Full Text] [Related]
17. Effects of exportin 1 on nuclear transport and meiotic resumption in porcine full-grown and growing oocytes.
Onuma A; Fujioka YA; Fujii W; Sugiura K; Naito K
Biol Reprod; 2018 Apr; 98(4):501-509. PubMed ID: 29228114
[TBL] [Abstract][Full Text] [Related]
18. XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose.
Crochiere ML; Hannus S; Hansen K; Becker F; Baloglu E; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2017 Dec; 8(66):110503-110516. PubMed ID: 29299164
[TBL] [Abstract][Full Text] [Related]
19. Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.
Jardin F; Pujals A; Pelletier L; Bohers E; Camus V; Mareschal S; Dubois S; Sola B; Ochmann M; Lemonnier F; Viailly PJ; Bertrand P; Maingonnat C; Traverse-Glehen A; Gaulard P; Damotte D; Delarue R; Haioun C; Argueta C; Landesman Y; Salles G; Jais JP; Figeac M; Copie-Bergman C; Molina TJ; Picquenot JM; Cornic M; Fest T; Milpied N; Lemasle E; Stamatoullas A; Moeller P; Dyer MJ; Sundstrom C; Bastard C; Tilly H; Leroy K
Am J Hematol; 2016 Sep; 91(9):923-30. PubMed ID: 27312795
[TBL] [Abstract][Full Text] [Related]
20. Clinical translation of nuclear export inhibitors in cancer.
Senapedis WT; Baloglu E; Landesman Y
Semin Cancer Biol; 2014 Aug; 27():74-86. PubMed ID: 24755012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
